Department of Surgery, The University of Auckland, Auckland, New Zealand.
Department of Anatomy and Medical Imaging, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.
Int Forum Allergy Rhinol. 2019 Sep;9(9):958-970. doi: 10.1002/alr.22376.
Optimizing intranasal distribution and retention of nasal sprays is essential in the management of patients with chronic rhinosinusitis (CRS), including those that have had functional endoscopic sinus surgery (FESS). Despite multiple existing distribution studies, there remains a need for a technique that allows regionalization of particle deposition within a patient's unique 3-dimensional (3D) geometry without exposing the patient to radiation.
Seven participants delivered normal saline containing a gadolinium-based contrast agent (GBCA) by either saline irrigation or nasal sprays on 1 side of the nasal cavity. The saline irrigation group included 2 participants (both healthy) while the nasal spray group included 5 participants (2 healthy, 2 post-FESS patients, 1 CRS patient without any sinus surgery). The distribution of new signal enhancement was assessed on each participant using magnetic resonance imaging (MRI). Serial scans were performed over an interval of 4 minutes in the nasal spray group to assess changes in intranasal distribution over time.
Signal enhancement was widespread within the nasal cavities and maxillary sinuses of participants (both healthy) that underwent sinus irrigation. For the nasal spray participants, the hotspots for signal enhancement were similar regardless of disease status or previous history of surgery. These included the internal nasal valve, anterior septum, inferior surface of the inferior turbinate, nasal floor, and nasopharynx. No signal enhancement was detected with nasal sprays in either unoperated or operated paranasal sinuses.
A technique has been developed using MRI evaluation of radioopaque contrast to characterize the temporospatial distribution of topical drug delivery within the sinonasal cavities.
优化鼻腔喷雾剂的鼻腔内分布和保留对于慢性鼻-鼻窦炎(CRS)患者的管理至关重要,包括那些已经接受过功能性内窥镜鼻窦手术(FESS)的患者。尽管已经有多项现有的分布研究,但仍需要一种技术,能够在不使患者暴露于辐射的情况下,将患者的独特三维(3D)几何结构内的粒子沉积进行分区。
7 名参与者通过生理盐水冲洗或鼻腔喷雾将含有钆基造影剂(GBCA)的生理盐水单侧鼻腔给药。生理盐水冲洗组包括 2 名参与者(均健康),而鼻腔喷雾组包括 5 名参与者(2 名健康,2 名 FESS 后患者,1 名无任何鼻窦手术的 CRS 患者)。使用磁共振成像(MRI)评估每个参与者新的信号增强分布。在鼻腔喷雾组中,在 4 分钟的间隔内进行连续扫描,以评估随时间的鼻腔内分布变化。
接受鼻窦冲洗的参与者(均健康)的鼻腔和上颌窦内信号增强广泛分布。对于鼻腔喷雾组的参与者,无论疾病状态或先前手术史如何,信号增强的热点都相似。这些热点包括内鼻阀、前鼻中隔、下鼻甲的下表面、鼻底和鼻咽。在未手术或手术的副鼻窦中,均未检测到鼻腔喷雾的信号增强。
已经开发出一种使用 MRI 评估不透射线造影剂的技术,用于描述鼻-鼻窦腔内局部药物输送的时空分布。